The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn’s disease

INTRODUCTION: The clinical efficacy of infliximab (IFX) for induction of remission in both adults and children with active Crohn’s disease (CD) has been well documented. Recently, so-called “deep remission” defined as mucosal healing has become the ultimate endpoint of the most recent therapeutic ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymanska, Edyta, Dadalski, Maciej, Szymanska, Sylwia, Grajkowska, Wieslawa, Pronicki, Maciej, Kierkus, Jaroslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047967/
https://www.ncbi.nlm.nih.gov/pubmed/27713779
http://dx.doi.org/10.5114/pg.2016.57753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047967/
https://www.ncbi.nlm.nih.gov/pubmed/27713779
http://dx.doi.org/10.5114/pg.2016.57753

Ejemplares similares